Zanil and associated names, and generic products thereof

Current status:
European Commission final decision

Overview

On 13 July 2017, the European Medicines Agency (the Agency) completed a review of the consumer safety of the withdrawal periods (meat, milk and offal) for cattle, sheep and goats for Zanil and associated names, and generic products thereof. The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the overall benefit-risk balance for the concerned products is positive and recommended amendments to withdrawal periods for cattle, sheep and goats to provide assurance for consumer safety.

Key facts

Approved name
Zanil and associated names, and generic products thereof
International non-proprietary name (INN) or common name
oxyclozanide
Associated names
  • Zanil Suspension
  • Zanil Fluke Drench
  • Zanil Fluke Drench 34 mg/ml Oral Suspension
Reference number
EMEA/V/A/124
Type
Article 35

Community interest referral: initiated in cases involving the interests of the Community or concerns relating to the protection of human or animal health or the environment.

Status
European Commission final decision
Opinion date
13/07/2017
EC decision date
28/09/2017

All documents

Document description

  • Opinion - contains the CVMP opinion of the referred medicine(s)
  • List of the medicines affected by the referral (Annex I)
  • Scientific conclusions of the Committee (Annex II)

The following two documents may not always be available:

How useful was this page?

Add your rating